Home › Funds › Callahan Advisors, LLC › CVS
Callahan Advisors, LLC position in CVS
CVS HEALTH CORP · Consumer Staples
Callahan Advisors, LLC reported holding 111,664 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$9.6M, representing 0.73% of its reported portfolio and ranking #40 among its reported holdings. Callahan Advisors, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Callahan Advisors, LLC's CVS position evolved
Callahan Advisors, LLC first disclosed a stake in CVS in Q3 2023 at 68,730 shares (US$4.8M). The position peaked in Q2 2026 at 110,374 shares, worth US$11.4M. Across 13 filings, Callahan Advisors, LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 111,664 shares valued at US$9.6M — an increase of 1,290 shares quarter over quarter.. Notable position changes include a 36% trim in Q2 2024 (shares rose 8% over the following quarter), a 25% trim in Q3 2024 (shares fell 28% over the following quarter), a 137% increase in Q2 2025 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 68.73K | $4.80M | New |
| Q4 2023 | 70.42K | $5.56M | Add |
| Q1 2024 | 71.42K | $5.70M | Add |
| Q2 2024 | 45.77K | $2.70M | Reduce |
| Q3 2024 | 34.13K | $2.15M | Reduce |
| Q4 2024 | 29.25K | $1.31M | Reduce |
| Q1 2025 | 32.37K | $2.19M | Add |
| Q2 2025 | 76.65K | $5.29M | Add |
| Q3 2025 | 88.81K | $6.70M | Add |
| Q4 2025 | 90.91K | $7.21M | Add |
| Q1 2026 | 103.08K | $7.40M | Add |
| Q2 2026 | 110.37K | $11.42M | Add |
| Q3 2026 | 111.66K | $9.57M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.04M sh · $6.35B · Q3 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.90M sh · $1.02B · Q3 2026
- Pzena Investment Management 10.30M sh · $882.34M · Q3 2026
More on Callahan Advisors, LLC
FAQ
How long has Callahan Advisors, LLC held CVS?
Callahan Advisors, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Callahan Advisors, LLC's current position in CVS?
As of Q3 2026, Callahan Advisors, LLC holds 111.66K shares of CVS (CVS HEALTH CORP), valued at $9.57M, representing 0.73% of its reported portfolio and ranking #40.
Has Callahan Advisors, LLC been buying or selling CVS?
In the latest 13F filing (Q3 2026), Callahan Advisors, LLC increased its position in CVS. The position peaked in Q2 2026 at 110.37K shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.